Leuprolide acetate therapy in luteinizing hormone-dependent cushing's syndrome

New England Journal of Medicine

Volumn 341, Issue 21, 1999, Pages 1577-1581

  Lacroix, André ^a   Hamet, Pavel ^a   Boutin, Jean Marie ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CHORIONIC GONADOTROPIN; CISAPRIDE; CORTICOTROPIN; DEXAMETHASONE; FOLLITROPIN; GLUCAGON; GONADORELIN; HYDROCORTISONE; INSULIN; LEUPRORELIN; LUTEINIZING HORMONE; METOCLOPRAMIDE; PROTIRELIN; TETRACOSACTIDE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; HORMONAL REGULATION; HORMONE INHIBITION; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUTEINIZING HORMONE RELEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEROIDOGENESIS;

ADRENOCORTICOTROPIC HORMONE; CUSHING SYNDROME; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYDROCORTISONE; LEUPROLIDE; LUTEINIZING HORMONE; MIDDLE AGED;

EID: 0032734209     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199911183412104     Document Type: Article

References (32)

1. Lacroix A, Bolté E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Engl J Med 1992;327:974-80.
2. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 1992;327:981-6.
3. de Herder WW, Hofland LJ, Usdin TB, et al. Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. J Clin Endocrinol Metab 1996;81:3168-72.
4. Chabre O, Liakos P, Vivier J, et al. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab 1998;83:3134-43.
5. Lebrethon MC, Avallet O, Reznik Y, et al. Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients. J Clin Endocrinol Metab 1998;83:4514-9.
6. N'Diaye N, Hamet P, Tremblay J, Boutin J-M, Gaboury L, Lacroix A. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. J Clin Endocrinol Metab 1999;84:2616-22.
7. 1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab 1997;82:2414-22.
8. Ida K, Kaji H, Matsumoto H, et al. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide. Clin Endocrinol 1997;47:739-45.
9. Arnaldi G, Gasc J-M, de Keyzer Y, et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab 1998;83:2029-35.
10. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic β-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997;337:1429-34.
11. Willenberg HS, Stratakis CA, Marx C, Ehrhart-Bornstein M, Chrousos GP, Bornstein SR. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome. N Engl J Med 1998; 339:27-31.
12. N'Diaye N, Tremblay J, Hamet P, Lacroix A. Hormone receptor abnormalities in adrenal Cushing's syndrome. Horm Metab Res 1998;30: 440-6.
13. Lacroix A, Mircescu H, Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. Endocrinologist 1999;9:9-15.
14. Minegishi T, Nakamura K, Takakura Y, et al. Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Biophys Res Commun 1990;172:1049-54.
15. Segaloff DL, Ascoli M. The lutropin/choriogonadotropin receptor . . . 4 years later. Endocr Rev 1993;14:324-47.
16. Rao CV. The beginning of a new era in reproductive biology and medicine: expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in nongonadal tissues. J Physiol Pharmacol 1996;47:Suppl 1:41-53.
17. Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab 1996;81:2397-400.
18. Seron-Ferre M, Lawrence CC, Jaffe RB. Role of hCG in regulation of the fetal zone of the human fetal adrenal gland. J Clin Endocrinol Metab 1978;46:834-7.
19. Matsukura S, Kakita T, Sueoka S, et al. Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors. Cancer Res 1980; 40:3768-71.
20. Leinonen P, Ranta T, Siegberg R, Pelkonen R, Heikkilä P, Kahri A. Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency. Clin Endocrinol 1991;34:31-5.
21. Millington DS, Golder MP, Cowley T, et al. In vitro synthesis of steroids by a feminising adrenocortical carcinoma: effect of prolactin and other protein hormones. Acta Endocrinol 1976;82:561-71.
22. Takahashi H, Yoshizaki K, Kato H, et al. A gonadotrophin-responsive virilizing adrenal tumour identified as a mixed ganglioneuroma and adreno-cortical adenoma. Acta Endocrinol 1978;89:701-9.
23. Smith HC, Posen S, Clifton-Bligh P, Casey J. A testosterone-secreting adrenal cortical adenoma. Aust N Z J Med 1978;8:171-5.
24. de Lange WE, Pratt JJ, Doorenbos H. A gonadotrophin responsive testosterone producing adrenocortical adenoma and high gonadotrophin levels in an elderly woman. Clin Endocrinol 1980;12:21-8.
25. Lefebvre H, Contesse V, Delarue C, et al. Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype. Neuroscience 1992; 47:999-1007.
26. Lefebvre H, Contesse V, Delarue C, Vaudry H, Kuhn JM. Serotonergic regulation of adrenocortical function. Horm Metab Res 1998;30:398-403.
27. Mircescu H, Jilwan J, Hamet P, Lacroix A. Systematic clinical screening for abnormal hormone receptors in adrenal Cushing's syndrome. In: Program and abstracts of the 80th Annual Meeting of the Endocrine Society, New Orleans, June 24-27, 1998. Bethesda, Md.: Endocrine Society Press, 1998:80. abstract.
28. Reschini E, Giustina G, Crosignani PG, D'Alberton A. Spontaneous remission of Cushing syndrome after termination of pregnancy. Obstet Gynecol 1978;51:598-602.
29. Close CF, Mann MC, Watts JF, Taylor KG. ACTH-indcpendent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin Endocrinol (Oxf) 1993;39:375-9.
30. Wallace C, Toth EL, Lewanczuk RZ, Siminoski K. Pregnancy-induced Cushing's syndrome in multiple pregnancies. J Clin Endocrinol Metab 1996;81:15-21.
31. Wieland RG, Shaffer MB, Glove RP. Cushing's syndrome complicating pregnancy: a case report. Obstet Gynecol 1971;38:841-3.
32. Barnes RB, Ehrmann DA. Long-term suppression of testosterone after treatment with a gonadotropin releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor. J Clin Endocrinol Metab 1997;82:1746-8.